TH D CONGRESS SESSION S. RES. 577 - govinfo

III

S. RES. 577 117TH CONGRESS 2D SESSION

Designating April 2022 as ``Parkinson's Awareness Month''.

IN THE SENATE OF THE UNITED STATES

APRIL 6, 2022 Ms. STABENOW (for herself and Mr. THUNE) submitted the following

resolution; which was referred to the Committee on the Judiciary

RESOLUTION

Designating April 2022 as ``Parkinson's Awareness Month''. Whereas Parkinson's disease--

(1) affects 1,000,000 individuals in the United States;

(2) is the second most common neurodegenerative disease in the world;

(3) is believed to be caused by a combination of genetic and environmental factors; and

(4) is the 14th leading cause of death in the United States, according to the Centers for Disease Control and Prevention; Whereas it is estimated that, by the year 2037, the number of individuals with Parkinson's disease in the United States will nearly double, and the disease will cost the United States at least $79,000,000,000 annually;

VerDate Sep 11 2014 02:53 Apr 07, 2022 Jkt 029200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6300 E:\BILLS\SR577.IS SR577

pbinns on DSKJLVW7X2PROD with BILLS

2

Whereas the symptoms of Parkinson's disease can include dementia and cognitive impairment, tremors, slowness of movement, ``freezing'' in place, inability to walk and maintain balance, speech difficulties, depression, losing the ability to swallow, and a variety of other symptoms;

Whereas there are millions of family caregivers, friends, and loved ones whose lives are greatly affected by Parkinson's disease; and

Whereas more research, education, and community support services are needed to-- (1) find better treatments and a cure for Parkinson's disease; and (2) maintain dignity for those living with the disease today: Now, therefore, be it

1

Resolved, That the Senate--

2

(1) designates April 2022 as ``Parkinson's

3

Awareness Month'';

4

(2) supports the goals and ideals of Parkinson's

5

Awareness Month;

6

(3) continues to support research to find better

7

treatments and a cure for Parkinson's disease;

8

(4) recognizes the individuals living with Par-

9

kinson's disease who participate in vital clinical

10

trials to advance the knowledge of the disease; and

11

(5) commends the dedication of organizations,

12

volunteers, researchers, and millions of individuals

13

across the country working to improve the quality of

pbinns on DSKJLVW7X2PROD with BILLS

?SRES 577 IS

VerDate Sep 11 2014 02:53 Apr 07, 2022 Jkt 029200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\SR577.IS SR577

3

1

life of people living with Parkinson's disease and

2

their families.

?

pbinns on DSKJLVW7X2PROD with BILLS

?SRES 577 IS

VerDate Sep 11 2014 02:53 Apr 07, 2022 Jkt 029200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6301 E:\BILLS\SR577.IS SR577

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download